Balsm Alofoq Medical Co (SAU:9620) Notes Receivable: ﷼0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9620 Balsm Alofoq Medical Co SAU:9620
24 GF Score
Price ﷼24.70
! 4 Warning Signs
View Full Analysis

What is Balsm Alofoq Medical Co Notes Receivable?

Balsm Alofoq Medical Co SAU:9620 24 Notes Receivable is ﷼0.00 Mil as of Dec. 2025. GuruFocus rates SAU:9620 with a GF Score™ of 24/100. The stock has 4 warning signs investors should review.

Balsm Alofoq Medical Co's Notes Receivable for the quarter that ended in Dec. 2025 was ﷼0.00 Mil.

Balsm Alofoq Medical Co Notes Receivable Related Terms

Balsm Alofoq Medical Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Balsm Alofoq Medical Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balsm Alofoq Medical Co Notes Receivable Chart

Balsm Alofoq Medical Co Annual Data
Trend Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00

Balsm Alofoq Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable 0.00 0.00 0.00 0.00 0.00
SAU:9620
24GF Score
Balsm Alofoq Medical Co SAU:9620
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balsm Alofoq Medical Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ﷼0.00 Mil mean?
Balsm Alofoq Medical Co (SAU:9620) has a Notes Receivable of ﷼0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Balsm Alofoq Medical Co and its competitors.
Is Balsm Alofoq Medical Co's Notes Receivable too high?
Balsm Alofoq Medical Co's current Notes Receivable is ﷼0.00 Mil. Overall, Balsm Alofoq Medical Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's Notes Receivable compare to ABT and SYK?
Balsm Alofoq Medical Co's Notes Receivable of ﷼0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Balsm Alofoq Medical Co and its competitors. Balsm Alofoq Medical Co's current Notes Receivable is ﷼0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current Notes Receivable of ﷼0.00 Mil. The current Notes Receivable is ﷼0.00 Mil. Balsm Alofoq Medical Co's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current Notes Receivable is ﷼0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Balsm Alofoq Medical Co Business Description

Address King Khalid Road, Qassim Region, Al-Ufuq District, Buraidah, SAU
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
24GF Score

Get the complete analysis for SAU:9620

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼24.70
Price